![](/img/cover-not-exists.png)
Effects of K-877, a novel selective PPARα modulator (SPPARMα), in dyslipidaemic patients: A randomized, double blind, active- and placebo-controlled, phase 2 trial
Ishibashi, Shun, Yamashita, Shizuya, Arai, Hidenori, Araki, Eiichi, Yokote, Koutaro, Suganami, Hideki, Fruchart, Jean-Charles, Kodama, TatsuhikoVolume:
249
Language:
english
Journal:
Atherosclerosis
DOI:
10.1016/j.atherosclerosis.2016.02.029
Date:
June, 2016
File:
PDF, 697 KB
english, 2016